
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter K - Tobacco Products
#### PART 1107 - EXEMPTION REQUESTS AND SUBSTANTIAL EQUIVALENCE REPORTS
##### Subpart D - FDA Review
###### ยง 1107.42 Review cycles.
####### Additional review cycles.

(b)If FDA issues a deficiency notification under ยง 1107.40(d) during the initial review cycle, FDA will stop reviewing the SE Report until it receives a response from the applicant or the timeframe specified in the notification of deficiencies for response has elapsed. If the applicant fails to respond within the time period provided in the notification of deficiency, FDA will issue an order denying marketing authorization under the criteria set forth in ยง 1107.48. If the applicant's response to the notification of deficiencies provides the information FDA requested, but FDA identifies additional deficiencies, FDA may issue an additional deficiency notification. Each response will begin a new 90-day review cycle.
